Uncategorized

24.02.2022

Hanmi Pharm Set to Produce COVID-19 Treatment for Merck and Supply to Developing Countries

Hanmi Pharmaceutical is set to manufacture a generic drug of Merck’s oral COVID-19 treatment drug and supply it to underdeveloped countries. On January 20th, Hanmi Pharmaceutical announced that it has recently signed a production agreement with the Medicines Patent Pool (MPP) for granting the right to produce molnupiravir (brand name: Lagevrio) developed by Merck of the United States. Under this […]
Freccia torna in alto